Results
1
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
1 companies
Biomark Diagnostics
Market Cap: €35.5m
Develops early-stage cancer diagnostic technology platform to detect and treat cancer.
20B
€0.34
7D
0.6%
1Y
152.2%